Bandingkan Harga & Kinerja Merdeka Battery Materials Tbk. (MBMA) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Merdeka Battery Materials Tbk. dan Organon Pharma Indonesia Tbk.: Merdeka Battery Materials Tbk. diperdagangkan di Rp520 (kapitalisasi pasar 57,24 T, volume 24 jam 89,37 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Merdeka Battery Materials Tbk. jauh lebih besar — sekitar 548,3× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| MBMA | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 57,24 T | 104,4 M |
Volume | 89,37 jt | — |
Lot | 893,72 rb | — |
Perputaran | 46,3 M | — |
Harga Rata-rata | 518,08 | — |
Nilai Transaksi | 46,3 M | — |
Harga Ekuilibrium Indikatif | 520 | — |
Volume Ekuilibrium Indikatif | 90,42 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Merdeka Battery Materials Tbk.
PT Merdeka Battery Materials Tbk (formerly PT Hamparan Logistik Nusantara) (the “Company”) was established based on Notarial Deed No. 66 of Darmawan Tjoa, S.H., S.E., Notary in Jakarta, dated 20 August 2019. The Company’s immediate parent entity is PT Merdeka Energi Nusantara (formerlyPT Batutua Tambang Abadi) (“MEN”) and its ultimate parent entity is PT Merdeka Copper Gold Tbk (“MDKA”), a company incorporated in Indonesia and listed on the Indonesian Stock Exchange (“IDX”).
Selengkapnya di halaman MBMA →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
